{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:07:11Z","timestamp":1781042831375,"version":"3.54.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cardiacep.theclinics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiac Electrophysiology Clinics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ccep.2024.09.001","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T02:17:10Z","timestamp":1731723430000},"page":"63-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Atrial Fibrillation Management with Guideline-Directed Medical Therapy and Comorbidity Treatment in Heart Failure Patients"],"prefix":"10.1016","volume":"17","author":[{"given":"Alvise","family":"Del Monte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sarkozy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik H.","family":"Verbrugge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"36","key":"10.1016\/j.ccep.2024.09.001_bib1","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ccep.2024.09.001_bib2","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes","volume":"120","author":"Staerk","year":"2017","journal-title":"Circ Res"},{"issue":"23","key":"10.1016\/j.ccep.2024.09.001_bib3","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ccep.2024.09.001_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jchf.2017.05.001","article-title":"Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"5","author":"Sartipy","year":"2017","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1016\/j.ccep.2024.09.001_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jacc.2019.11.013","article-title":"Atrial failure as a clinical entity: JACC review topic of the week","volume":"75","author":"Bisbal","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccep.2024.09.001_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCHEARTFAILURE.114.001667","article-title":"Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction","volume":"8","author":"Melenovsky","year":"2015","journal-title":"Circ Heart Fail"},{"issue":"9","key":"10.1016\/j.ccep.2024.09.001_bib7","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2020.07.009","article-title":"Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation","volume":"76","author":"Reddy","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.ccep.2024.09.001_bib8","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial","volume":"133","author":"Di Biase","year":"2016","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccep.2024.09.001_bib9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.ccep.2024.09.001_bib10","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.120.050991","article-title":"Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.ccep.2024.09.001_bib11","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJMoa2306037","article-title":"Catheter ablation in end-stage heart failure with atrial fibrillation","volume":"389","author":"Sohns","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ccep.2024.09.001_bib12","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/CIRCULATIONAHA.119.045409","article-title":"Altered hemodynamics and end-organ damage in heart failure: impact on the lung and kidney","volume":"142","author":"Verbrugge","year":"2020","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ccep.2024.09.001_bib13","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/europace\/euw161","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication","volume":"18","author":"Goette","year":"2016","journal-title":"Europace"},{"issue":"7","key":"10.1016\/j.ccep.2024.09.001_bib14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0002-9149(84)80203-9","article-title":"Atrial conduction: effects of extrastimuli with and without atrial dysrhythmias","volume":"54","author":"Buxton","year":"1984","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.ccep.2024.09.001_bib15","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/cvr\/23.10.882","article-title":"The effect of atrial dilatation on the genesis of atrial arrhythmias","volume":"23","author":"Solti","year":"1989","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.ccep.2024.09.001_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.100.1.87","article-title":"Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort","volume":"100","author":"Li","year":"1999","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ccep.2024.09.001_bib17","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/jce.13093","article-title":"B-type natriuretic peptide modulates pulmonary vein arrhythmogenesis: a novel potential contributor to the genesis of atrial tachyarrhythmia in heart failure","volume":"27","author":"Lin","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"2\u20133","key":"10.1016\/j.ccep.2024.09.001_bib18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pbiomolbio.2008.02.019","article-title":"Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria","volume":"97","author":"Eckstein","year":"2008","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.ccep.2024.09.001_bib19","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3389\/fphys.2018.01380","article-title":"Calcium in the pathophysiology of atrial fibrillation and heart failure","volume":"9","author":"Denham","year":"2018","journal-title":"Front Physiol"},{"issue":"6 Suppl","key":"10.1016\/j.ccep.2024.09.001_bib20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.hrthm.2008.01.016","article-title":"Cellular bases for human atrial fibrillation","volume":"5","author":"Workman","year":"2008","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccep.2024.09.001_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fphar.2017.00313","article-title":"Mineralocorticoid receptor signaling as a therapeutic target for renal and cardiac fibrosis","volume":"8","author":"Tesch","year":"2017","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.ccep.2024.09.001_bib22","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/eurheartj\/eht456","article-title":"Peripheral venous congestion causes inflammation, neurohormonal, and endothelial cell activation","volume":"35","author":"Colombo","year":"2014","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ccep.2024.09.001_bib23","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/ijms25021082","article-title":"The role of pro-inflammatory cytokines in the pathogenesis of cardiovascular disease","volume":"25","author":"Zhang","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"19","key":"10.1016\/j.ccep.2024.09.001_bib24","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.jacc.2019.02.061","article-title":"Atrial functional mitral regurgitation: JACC review topic of the week","volume":"73","author":"Deferm","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ccep.2024.09.001_bib25","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0735-1097(97)00254-4","article-title":"Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation","volume":"30","author":"Clark","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.ccep.2024.09.001_bib26","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jacc.2014.06.1205","article-title":"Contribution of the diastolic vortex ring to left ventricular filling","volume":"64","author":"Martinez-Legazpi","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccep.2024.09.001_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0735-1097(98)00221-6","article-title":"Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm","volume":"32","author":"Pozzoli","year":"1998","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ccep.2024.09.001_bib28","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0002-9149(97)89297-1","article-title":"Effect of an irregular ventricular rhythm on cardiac output","volume":"78","author":"Daoud","year":"1996","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ccep.2024.09.001_bib29","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.3390\/ijms16023133","article-title":"Heart failure and atrial fibrillation: from basic science to clinical practice","volume":"16","author":"Ferreira","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.ccep.2024.09.001_bib30","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.hrthm.2008.04.023","article-title":"Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction","volume":"5","author":"Dandamudi","year":"2008","journal-title":"Heart Rhythm"},{"issue":"18","key":"10.1016\/j.ccep.2024.09.001_bib31","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.jacc.2019.02.045","article-title":"Arrhythmia-induced cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Huizar","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ccep.2024.09.001_bib32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/hrt.74.3.261","article-title":"Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation","volume":"74","author":"Edner","year":"1995","journal-title":"Br Heart J"},{"issue":"1","key":"10.1016\/j.ccep.2024.09.001_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmg.2021.05.019","article-title":"Mitral annular dynamics in AF versus sinus rhythm: novel insights into the mechanism of AFMR","volume":"15","author":"Deferm","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"9","key":"10.1016\/j.ccep.2024.09.001_bib34","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A\u00a0simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccep.2024.09.001_bib35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ccep.2024.09.001_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1817591","article-title":"Alcohol abstinence in drinkers with atrial fibrillation","volume":"382","author":"Voskoboinik","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ccep.2024.09.001_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.hrthm.2018.10.041","article-title":"Moderate alcohol consumption is associated with atrial electrical and structural changes: insights from high-density left atrial electroanatomic mapping","volume":"16","author":"Voskoboinik","year":"2019","journal-title":"Heart Rhythm"},{"issue":"21","key":"10.1016\/j.ccep.2024.09.001_bib38","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/bjsports-2021-103994","article-title":"Risk of atrial fibrillation in athletes: a systematic review and meta-analysis","volume":"55","author":"Newman","year":"2021","journal-title":"Br J Sports Med"},{"issue":"12","key":"10.1016\/j.ccep.2024.09.001_bib39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11936-018-0697-9","article-title":"Atrial fibrillation (AF) in endurance athletes: a complicated affair","volume":"20","author":"Stergiou","year":"2018","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"9","key":"10.1016\/j.ccep.2024.09.001_bib40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated cardiomyopathy: the complexity of a diverse genetic architecture","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.ccep.2024.09.001_bib41","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1038\/s41598-022-07534-4","article-title":"Association between lung function and the risk of atrial fibrillation in a nationwide population cohort study","volume":"12","author":"Lee","year":"2022","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.ccep.2024.09.001_bib42","first-page":"e003521","article-title":"Right atrial function in pulmonary arterial hypertension","volume":"8","author":"Querejeta","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.ccep.2024.09.001_bib43","doi-asserted-by":"crossref","first-page":"00414","DOI":"10.1183\/23120541.00414-2020","article-title":"Prognostic value of right atrial dilation in patients with pulmonary embolism","volume":"7","author":"Lerchbaumer","year":"2021","journal-title":"ERJ Open Res"},{"issue":"14","key":"10.1016\/j.ccep.2024.09.001_bib44","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ccep.2024.09.001_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2212540","article-title":"Progression of atrial fibrillation after cryoablation or drug therapy","volume":"388","author":"Andrade","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.ccep.2024.09.001_bib46","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1161\/01.CIR.0000072793.81076.D4","article-title":"Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies of Left Ventricular Dysfunction (SOLVD) trials","volume":"107","author":"Vermes","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccep.2024.09.001_bib47","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/01.CIR.100.4.376","article-title":"Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction","volume":"100","author":"Pedersen","year":"1999","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccep.2024.09.001_bib48","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ahj.2004.09.033","article-title":"Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT)","volume":"149","author":"Maggioni","year":"2005","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ccep.2024.09.001_bib49","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ahj.2005.06.036","article-title":"Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"152","author":"Ducharme","year":"2006","journal-title":"Am Heart J"},{"issue":"11","key":"10.1016\/j.ccep.2024.09.001_bib50","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.jacc.2004.11.070","article-title":"Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis","volume":"45","author":"Healey","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccep.2024.09.001_bib51","first-page":"100","article-title":"Favorable effects of sacubitril\/valsartan on the peak atrial longitudinal strain in patients with chronic heart failure and a history of one or more episodes of atrial fibrillation: a retrospective cohort study","volume":"12","author":"De Vecchis","year":"2020","journal-title":"J\u00a0Clin Med Res"},{"issue":"11","key":"10.1016\/j.ccep.2024.09.001_bib52","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccep.2024.09.001_bib53","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jchf.2022.01.018","article-title":"Atrial fibrillation in heart failure with preserved ejection fraction: the PARAGON-HF trial","volume":"10","author":"Cikes","year":"2022","journal-title":"JACC Heart Fail"},{"issue":"4","key":"10.1016\/j.ccep.2024.09.001_bib54","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2004.09.076","article-title":"Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the carvedilol post-infarct survival control in left ventricular dysfunction (CAPRICORN) trial","volume":"45","author":"McMurray","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9961","key":"10.1016\/j.ccep.2024.09.001_bib55","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis","volume":"384","author":"Kotecha","year":"2014","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.ccep.2024.09.001_bib56","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1093\/eurheartj\/ehad141","article-title":"Heart failure with preserved ejection fraction: relevance of a dedicated dyspnoea clinic","volume":"44","author":"Verwerft","year":"2023","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.ccep.2024.09.001_bib57","doi-asserted-by":"crossref","first-page":"e013267","DOI":"10.1161\/JAHA.119.013267","article-title":"Effects of mineralocorticoid receptor antagonists on atrial fibrillation occurrence: a systematic review, meta-analysis, and meta-regression to identify modifying factors","volume":"8","author":"Alexandre","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.ccep.2024.09.001_bib58","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jacc.2021.04.079","article-title":"Finerenone reduces new-onset atrial fibrillation in patients with chronic kidney disease and type 2 diabetes","volume":"78","author":"Filippatos","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.ccep.2024.09.001_bib59","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","article-title":"Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (eplerenone in Mild patients hospitalization and SurvIval study in heart failure) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccep.2024.09.001_bib60","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40256-019-00353-5","article-title":"Effect of spironolactone on atrial fibrillation in patients with heart failure with preserved ejection fraction: post-hoc analysis of the randomized, placebo-controlled TOPCAT trial","volume":"20","author":"Neefs","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"issue":"17","key":"10.1016\/j.ccep.2024.09.001_bib61","doi-asserted-by":"crossref","first-page":"e022222","DOI":"10.1161\/JAHA.121.022222","article-title":"Sodium-glucose Co-transporter inhibitors and atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Pandey","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.ccep.2024.09.001_bib62","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/eurjpc\/zwad356","article-title":"Sodium-glucose co-transporter-2 inhibitors for the prevention of atrial fibrillation: a systemic review and meta-analysis","volume":"31","author":"Zhang","year":"2024","journal-title":"Eur J Prev Cardiol"},{"issue":"15","key":"10.1016\/j.ccep.2024.09.001_bib63","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.119.044183","article-title":"Effect of dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus: insights from the DECLARE-TIMI 58 trial","volume":"141","author":"Zelniker","year":"2020","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ccep.2024.09.001_bib64","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.jacep.2023.06.008","article-title":"Impact of SGLT2 inhibitors on AF recurrence after catheter ablation in patients with type 2 diabetes","volume":"9","author":"Abu-Qaoud","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"issue":"11","key":"10.1016\/j.ccep.2024.09.001_bib65","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.120.045691","article-title":"Empagliflozin in heart failure: diuretic and cardiorenal effects","volume":"142","author":"Griffin","year":"2020","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccep.2024.09.001_bib66","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jcmg.2019.12.008","article-title":"LA mechanics in decompensated heart failure: insights from strain echocardiography with invasive hemodynamics","volume":"13","author":"Deferm","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.ccep.2024.09.001_bib67","doi-asserted-by":"crossref","first-page":"e008176","DOI":"10.1161\/CIRCHEARTFAILURE.120.008176","article-title":"Detection of left atrial myopathy using artificial intelligence-enabled electrocardiography","volume":"15","author":"Verbrugge","year":"2022","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10.1016\/j.ccep.2024.09.001_bib68","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1183\/09031936.03.00051502","article-title":"Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study","volume":"21","author":"Buch","year":"2003","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.ccep.2024.09.001_bib69","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jacep.2022.04.015","article-title":"Impact of CPAP on the atrial fibrillation substrate in obstructive sleep apnea: the SLEEP-AF study","volume":"8","author":"Nalliah","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"issue":"5","key":"10.1016\/j.ccep.2024.09.001_bib70","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1164\/rccm.202011-4133OC","article-title":"Effect of continuous positive airway pressure on arrhythmia in atrial fibrillation and sleep apnea: a randomized controlled trial","volume":"204","author":"Traaen","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccep.2024.09.001_bib71","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jcmg.2020.09.032","article-title":"Evolution of myocardial dysfunction in asymptomatic patients at risk of heart failure","volume":"14","author":"Halabi","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.ccep.2024.09.001_bib72","doi-asserted-by":"crossref","first-page":"e009115","DOI":"10.1161\/CIRCEP.120.009115","article-title":"Metformin is associated with a lower risk of atrial fibrillation and ventricular arrhythmias compared with sulfonylureas: an observational study","volume":"14","author":"Ostropolets","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"12","key":"10.1016\/j.ccep.2024.09.001_bib73","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ccep.2024.09.001_bib74","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacbts.2023.01.005","article-title":"Glucagon-like peptide-1 protects against atrial fibrillation and atrial remodeling in type 2 diabetic mice","volume":"8","author":"Bohne","year":"2023","journal-title":"JACC Basic Transl Sci"}],"container-title":["Cardiac Electrophysiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918224000467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918224000467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T17:45:44Z","timestamp":1749836744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877918224000467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1877918224000467"],"URL":"https:\/\/doi.org\/10.1016\/j.ccep.2024.09.001","relation":{},"ISSN":["1877-9182"],"issn-type":[{"value":"1877-9182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial Fibrillation Management with Guideline-Directed Medical Therapy and Comorbidity Treatment in Heart Failure Patients","name":"articletitle","label":"Article Title"},{"value":"Cardiac Electrophysiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccep.2024.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}